- Home
- AMLX vs CPRI Comparison
AMLX vs CPRI Comparison
Compare AMLX & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | CPRI |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMLX | CPRI |
|---|---|---|
| Price | $34.54 | $13.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $21.56 | ★ $26.62 |
| AVG Volume (30 Days) | 3.5M | ★ 4.0M |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.46 | ★ 111.40 |
| EPS | N/A | ★ 0.60 |
| Revenue | $380,786,000.00 | ★ $3,474,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.81 |
| P/E Ratio | ★ N/A | $21.98 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $9.15 | $13.05 |
| 52 Week High | $41.14 | $28.27 |
Technical Indicators
Market Signals| Indicator | AMLX | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 71.92 | 31.50 |
| Support Level | $12.54 | N/A |
| Resistance Level | $41.14 | $15.90 |
| Average True Range (ATR) | 2.27 | 0.51 |
| MACD | 0.63 | -0.07 |
| Stochastic Oscillator | 75.83 | 13.86 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.